Shea Jacqueline Elizabeth 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Shea Jacqueline Elizabeth
DirectorChief Executive Officer
Transactions
- Award
Common Stock Option
[F1]2026-03-04+97,240→ 97,240 totalExercise: $1.73Exp: 2036-02-26→ Common Stock (97,240 underlying) - Award
Restricted Stock Unit
[F2]2026-03-04+78,760→ 78,760 total→ Common Stock (78,760 underlying)
Footnotes (2)
- [F1]The vesting schedule for the 97,240 options granted on March 4, 2026 was as follows: 32,414 shares will vest on February 26, 2027; 32,413 shares will vest on February 26, 2028; 32,413 shares will vest on February 26, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Signature
/s/ Jacqueline E. Shea|2026-03-05